|
JP5921525B2
(ja)
*
|
2010-03-22 |
2016-05-24 |
リード ディスカバリー センター ゲゼルシャフト ミット ベシュレンクテル ハフツング |
医薬的に活性のある二置換のトリアジン誘導体
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
EP2755948B1
(en)
|
2011-09-16 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
|
|
ES2587284T3
(es)
|
2011-09-16 |
2016-10-21 |
Bayer Intellectual Property Gmbh |
5-Fluoro-pirimidinas 2,4-disustituidas como inhibidores selectivos de CDK9
|
|
US8598937B2
(en)
|
2011-10-07 |
2013-12-03 |
Transphorm Inc. |
High power semiconductor electronic components with increased reliability
|
|
US8803246B2
(en)
|
2012-07-16 |
2014-08-12 |
Transphorm Inc. |
Semiconductor electronic components with integrated current limiters
|
|
CA2888371C
(en)
|
2012-10-18 |
2021-06-08 |
Ulrich Lucking |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
US20150259300A1
(en)
|
2012-10-18 |
2015-09-17 |
Bayer Pharma Aktiengesellschaft |
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group
|
|
CN105283453B
(zh)
*
|
2012-10-18 |
2018-06-22 |
拜耳药业股份公司 |
含砜基的n-(吡啶-2-基)嘧啶-4-胺衍生物
|
|
UA115254C2
(uk)
|
2012-11-15 |
2017-10-10 |
Баєр Фарма Акціенгезельшафт |
Похідні 5-фтор-n-(піридин-2-іл)піридин-2-аміну, що містять сульфоксімінову групу
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
US9087718B2
(en)
|
2013-03-13 |
2015-07-21 |
Transphorm Inc. |
Enhancement-mode III-nitride devices
|
|
US9245992B2
(en)
|
2013-03-15 |
2016-01-26 |
Transphorm Inc. |
Carbon doping semiconductor devices
|
|
WO2015001021A1
(en)
|
2013-07-04 |
2015-01-08 |
Bayer Pharma Aktiengesellschaft |
Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors
|
|
WO2015009514A1
(en)
|
2013-07-19 |
2015-01-22 |
Transphorm Inc. |
Iii-nitride transistor including a p-type depleting layer
|
|
CN106232596A
(zh)
|
2014-03-13 |
2016-12-14 |
拜耳医药股份有限公司 |
含有砜基团的5‑氟‑n‑(吡啶‑2‑基)吡啶‑2‑胺衍生物
|
|
EP3126338B1
(en)
|
2014-04-01 |
2019-09-04 |
Bayer Pharma Aktiengesellschaft |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
|
|
AP2016009483A0
(en)
|
2014-04-11 |
2016-10-31 |
Bayer Pharma AG |
Novel macrocyclic compounds
|
|
US9543940B2
(en)
|
2014-07-03 |
2017-01-10 |
Transphorm Inc. |
Switching circuits having ferrite beads
|
|
US9318593B2
(en)
|
2014-07-21 |
2016-04-19 |
Transphorm Inc. |
Forming enhancement mode III-nitride devices
|
|
ES2691227T3
(es)
|
2014-10-16 |
2018-11-26 |
Bayer Pharma Aktiengesellschaft |
Derivados fluorados de benzofuranil-pirimidina que contienen un grupo sulfoximina
|
|
CN107207475A
(zh)
|
2014-10-16 |
2017-09-26 |
拜耳医药股份有限公司 |
含有砜基团的氟化苯并呋喃基‑嘧啶衍生物
|
|
CN107428707A
(zh)
|
2015-03-24 |
2017-12-01 |
拜耳制药股份公司 |
4‑(4‑氟‑2‑甲氧基苯基)‑n‑{3‑[(s‑甲基亚磺酰亚胺基)甲基]苯基}‑1,3,5‑三嗪‑2‑胺用于治疗多发性骨髓瘤的用途
|
|
CN107427520A
(zh)
|
2015-03-24 |
2017-12-01 |
拜耳医药股份有限公司 |
4‑(4‑氟‑2‑甲氧基苯基)‑n‑{3‑[(s‑甲基磺酰亚氨基)甲基]苯基}‑1，3，5‑三嗪‑2‑胺用于治疗淋巴瘤的用途
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
LT3539961T
(lt)
|
2015-06-29 |
2021-12-27 |
Astrazeneca Ab |
Policikliniai amido dariniai, kaip cdk9 inhibitoriai
|
|
WO2017055196A1
(en)
|
2015-09-29 |
2017-04-06 |
Bayer Pharma Aktiengesellschaft |
Novel macrocyclic sulfondiimine compounds
|
|
ES2819869T3
(es)
|
2015-10-08 |
2021-04-19 |
Bayer Pharma AG |
Nuevos compuestos macrocíclicos modificados
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
WO2017123999A1
(en)
|
2016-01-15 |
2017-07-20 |
Transphorm Inc. |
Enhancement mode iii-nitride devices having an al(1-x)sixo gate insulator
|
|
WO2017210323A1
(en)
|
2016-05-31 |
2017-12-07 |
Transphorm Inc. |
Iii-nitride devices including a graded depleting layer
|
|
US11242356B2
(en)
|
2017-03-28 |
2022-02-08 |
Bayer Aktiengesellschaft |
PTEFb inhibiting macrocyclic compounds
|
|
WO2018177899A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
CA3090843A1
(en)
|
2018-02-13 |
2019-08-22 |
Bayer Aktiengesellschaft |
Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-n-{4-[(s-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large b-cell lymphoma
|